---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-016378"
form_type: "8-K"
ticker: "CHRS"
cik: "0001512762"
company_name: "Coherus Oncology, Inc."
filed_at: "2026-02-17T23:59:59+00:00"
generated_at: "2026-05-16T02:24:30.409862+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Coherus Oncology closes $47M public offering of 28.6M shares at $1.75/share

## Summary
- Issued 28.6M common shares at $1.75 public price; underwriters paid $1.645/share.
- Net proceeds of ~$47.0M after underwriting discounts and commissions.
- Underwriters have 30-day option to purchase up to 4.29M additional shares for over-allotments.
- Directors, officers, and certain stockholders subject to 60-day lock-up agreement.

## SEC filing metadata
- accession: 0001104659-26-016378
- form_type: 8-K
- ticker: CHRS
- cik: 0001512762
- company_name: Coherus Oncology, Inc.
- filed_at: 2026-02-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1512762/000110465926016378/0001104659-26-016378-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1512762/000110465926016378/chrs-20260212x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-016378
- JSON: https://secwatch.observer/filing/0001104659-26-016378.json
- Plain text: https://secwatch.observer/filing/0001104659-26-016378.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.